MétaCan
Menu
Back to cohort
Record W2097426308 · doi:10.1016/j.bbmt.2015.05.010

The Impact of Graft-versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning Regimen

2015· article· en· W2097426308 on OpenAlexaff
Álvaro Urbano-Ispizúa, Steven Z. Pavletic, Mary E.D. Flowers, John P. Klein, Mei-Jie Zhang, Jeanette Carreras, Silvia Montoto, Miguel‐Angel Perales, Mahmoud Aljurf, Görgün Akpek, Christopher Bredeson, Luciano J. Costa, Christopher E. Dandoy, César O. Freytes, Henry C. Fung, Robert Peter Gale, John Gibson, Mehdi Hamadani, Robert J. Hayashi, Yoshihiro Inamoto, David J. Inwards, Hillard M. Lazarus, David G. Maloney, Rodrigo Martino, Reinhold Munker, Taiga Nishihori, Richard F. Olsson, David A. Rizzieri, Ran Reshef, Ayman Saad, Bipin N. Savani, Harry C. Schouten, Sonali M. Smith, Gèrard Socié, Baldeep Wirk, Lolie C. Yu, Wael Saber

Bibliographic record

VenueBiology of Blood and Marrow Transplantation · 2015
Typearticle
Languageen
FieldMedicine
TopicLymphoma Diagnosis and Treatment
Canadian institutionsOttawa Hospital
FundersSt. Baldrick's FoundationTerumo BCTNational Cancer InstituteOffice of Naval ResearchNational Heart, Lung, and Blood InstituteHealth Resources and Services AdministrationMedacSwedish Orphan BiovitrumGlaxoSmithKlineKiadis PharmaMiltenyi BiotecOtsuka AmericaIncyteTherakosGenentechSeattle GeneticsChimerixU.S. Department of DefenseMedical College of WisconsinNational Institute of Allergy and Infectious DiseasesBlue Cross and Blue Shield AssociationTakeda OncologyUniversity of MinnesotaSigma-Tau PharmaceuticalsStemCyteTarix PharmaceuticalsSanofiUniversity of UtahHistoGeneticsWellPointTeva Pharmaceutical IndustriesHealth ResearchNational Marrow Donor ProgramRoswell Park Cancer InstituteFred Hutchinson Cancer Research CenterU.S. NavyCelgeneOsiris TherapeuticsMerckLeukemia and Lymphoma SocietyBe The Match FoundationAllos TherapeuticsU.S. Public Health ServiceActinium PharmaceuticalsAriad PharmaceuticalsOtsuka America PharmaceuticalAmgenOnyx Pharmaceuticals
KeywordsMedicineLymphomaInternal medicineTransplantationFollicular lymphomaRegimenHematopoietic stem cell transplantationIncidence (geometry)OncologyGraft-versus-host diseaseGastroenterologyMantle cell lymphomaImmunology

Abstract

fetched live from OpenAlex

The purpose of this study was to analyze the impact of graft-versus-host disease (GVHD) on the relapse rate of different lymphoma subtypes after allogeneic hematopoietic cell transplantation (allo-HCT). Adult patients with a diagnosis of Hodgkin lymphoma, diffuse large B cell lymphoma, follicular lymphoma (FL), peripheral T cell lymphoma, or mantle cell lymphoma (MCL) undergoing HLA-identical sibling or unrelated donor hematopoietic cell transplantation between 1997 and 2009 were included. Two thousand six hundred eleven cases were included. A reduced-intensity conditioning (RIC) regimen was used in 62.8% of the transplantations. In a multivariate analysis of myeloablative cases (n = 970), neither acute (aGVHD) nor chronic GVHD (cGVHD) were significantly associated with a lower incidence of relapse/progression in any lymphoma subtype. In contrast, the analysis of RIC cases (n = 1641) showed that cGVHD was associated with a lower incidence of relapse/progression in FL (risk ratio [RR], .51; P = .049) and in MCL (RR, .41; P = .019). Patients with FL or MCL developing both aGVHD and cGVHD had the lowest risk of relapse (RR, .14; P = .007; and RR, .15; P = .0019, respectively). Of interest, the effect of GVHD on decreasing relapse was similar in patients with sensitive disease and chemoresistant disease. Unfortunately, both aGVHD and cGVHD had a deleterious effect on treatment-related mortality and overall survival (OS) in FL cases but did not affect treatment-related mortality, OS or PFS in MCL. This study reinforces the use of RIC allo-HCT as a platform for immunotherapy in FL and MCL patients.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.004
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.001
Threshold uncertainty score0.006

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.004
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.015
GPT teacher head0.238
Teacher spread0.223 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations53
Published2015
Admission routes1
Has abstractyes

Explore more

Same venueBiology of Blood and Marrow TransplantationSame topicLymphoma Diagnosis and TreatmentFrench-language works237,207